According to Ionis Pharmaceuticals 's latest financial reports the company's total debt is $1.45 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $1.45 B | 6.16% |
2022-12-31 | $1.36 B | 9.44% |
2021-12-31 | $1.25 B | 37.64% |
2020-12-31 | $0.90 B | 18.05% |
2019-12-31 | $0.76 B | 22.59% |
2018-12-31 | $0.62 B | 5.93% |
2017-12-31 | $0.59 B | 3.49% |
2016-12-31 | $0.57 B | 24.11% |
2015-12-31 | $0.46 B | 3.21% |
2014-12-31 | $0.44 B | 101.8% |
2013-12-31 | $0.22 B | 3.3% |
2012-12-31 | $0.21 B | 1.52% |
2011-12-31 | $0.21 B | 36.86% |
2010-12-31 | $0.15 B | 9.63% |
2009-12-31 | $0.14 B | -19.29% |
2008-12-31 | $0.17 B | 2.59% |
2007-12-31 | $0.17 B | 21.21% |
2006-12-31 | $0.14 B | -5.02% |
2005-12-31 | $0.14 B | -40.22% |
2004-12-31 | $0.24 B | 7.52% |
2003-12-31 | $0.22 B | 0.52% |
2002-12-31 | $0.22 B | 68.72% |
2001-12-31 | $0.13 B |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $0.8 M | -99.94% | Bahamas |
NRC Health
NRC | $36.68 M | -97.48% | ๐บ๐ธ USA |